137 related articles for article (PubMed ID: 10880093)
1. Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation.
Jin QM; Takita H; Kohgo T; Atsumi K; Itoh H; Kuboki Y
J Biomed Mater Res; 2000 Sep; 51(3):491-9. PubMed ID: 10880093
[TBL] [Abstract][Full Text] [Related]
2. Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation.
Jin QM; Takita H; Kohgo T; Atsumi K; Itoh H; Kuboki Y
J Biomed Mater Res; 2000 Dec; 52(4):491-9. PubMed ID: 11033569
[No Abstract] [Full Text] [Related]
3. Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis.
Kuboki Y; Jin Q; Takita H
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S105-15. PubMed ID: 11314788
[TBL] [Abstract][Full Text] [Related]
4. Geometry of artificial ECM: sizes of pores controlling phenotype expression in BMP-induced osteogenesis and chondrogenesis.
Kuboki Y; Jin Q; Kikuchi M; Mamood J; Takita H
Connect Tissue Res; 2002; 43(2-3):529-34. PubMed ID: 12489210
[TBL] [Abstract][Full Text] [Related]
5. Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy.
Ono I; Yamashita T; Jin HY; Ito Y; Hamada H; Akasaka Y; Nakasu M; Ogawa T; Jimbow K
Biomaterials; 2004 Aug; 25(19):4709-18. PubMed ID: 15120517
[TBL] [Abstract][Full Text] [Related]
6. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
[TBL] [Abstract][Full Text] [Related]
7. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis.
Kuboki Y; Takita H; Kobayashi D; Tsuruga E; Inoue M; Murata M; Nagai N; Dohi Y; Ohgushi H
J Biomed Mater Res; 1998 Feb; 39(2):190-9. PubMed ID: 9457547
[TBL] [Abstract][Full Text] [Related]
8. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
Liang G; Yang Y; Oh S; Ong JL; Zheng C; Ran J; Yin G; Zhou D
Biomaterials; 2005 Jul; 26(20):4265-71. PubMed ID: 15683650
[TBL] [Abstract][Full Text] [Related]
9. Recombinant growth/differentiation factor-5 (GDF-5) stimulates osteogenic differentiation of marrow mesenchymal stem cells in porous hydroxyapatite ceramic.
Shimaoka H; Dohi Y; Ohgushi H; Ikeuchi M; Okamoto M; Kudo A; Kirita T; Yonemasu K
J Biomed Mater Res A; 2004 Jan; 68(1):168-76. PubMed ID: 14661262
[TBL] [Abstract][Full Text] [Related]
10. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
Takahashi Y; Yamamoto M; Tabata Y
Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
[TBL] [Abstract][Full Text] [Related]
11. Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation.
Someya A; Yuyama H; Fujimori A; Ukai M; Fukushima S; Sasamata M
Eur J Pharmacol; 2006 Aug; 543(1-3):14-20. PubMed ID: 16843458
[TBL] [Abstract][Full Text] [Related]
12. The induction of bone formation by coral-derived calcium carbonate/hydroxyapatite constructs.
Ripamonti U; Crooks J; Khoali L; Roden L
Biomaterials; 2009 Mar; 30(7):1428-39. PubMed ID: 19081131
[TBL] [Abstract][Full Text] [Related]
13. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
[TBL] [Abstract][Full Text] [Related]
14. Localization of bone morphogenetic protein-induced bone and cartilage formation on a new carrier: fibrous collagen membrane.
Shigenobu K; Kaneda K; Nagai N; Kuboki Y
Ann Chir Gynaecol Suppl; 1993; 207():85-90. PubMed ID: 8154842
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
16. BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate.
Tazaki J; Murata M; Akazawa T; Yamamoto M; Ito K; Arisue M; Shibata T; Tabata Y
Biomed Mater Eng; 2009; 19(2-3):141-6. PubMed ID: 19581707
[TBL] [Abstract][Full Text] [Related]
17. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis.
Tsuruga E; Takita H; Itoh H; Wakisaka Y; Kuboki Y
J Biochem; 1997 Feb; 121(2):317-24. PubMed ID: 9089406
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
19. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2).
Na K; Kim SW; Sun BK; Woo DG; Yang HN; Chung HM; Park KH
Biomaterials; 2007 Jun; 28(16):2631-7. PubMed ID: 17331575
[TBL] [Abstract][Full Text] [Related]
20. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: immunosuppressive and osteogenic potential of FK506 in vivo.
Yoshikawa T; Nakajima H; Yamada E; Akahane M; Dohi Y; Ohgushi H; Tamai S; Ichijima K
J Bone Miner Res; 2000 Jun; 15(6):1147-57. PubMed ID: 10841184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
